Modular Medical Statistics
Total Valuation
Modular Medical has a market cap or net worth of $25.33 million. The enterprise value is $17.81 million.
| Market Cap | 25.33M |
| Enterprise Value | 17.81M |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026, after market close.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Modular Medical has 5.41 million shares outstanding. The number of shares has increased by 63.25% in one year.
| Current Share Class | 5.41M |
| Shares Outstanding | 5.41M |
| Shares Change (YoY) | +63.25% |
| Shares Change (QoQ) | +18.63% |
| Owned by Insiders (%) | 2.33% |
| Owned by Institutions (%) | 19.20% |
| Float | 4.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 13.53 |
| PB Ratio | 1.62 |
| P/TBV Ratio | 1.88 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.03, with a Debt / Equity ratio of 0.03.
| Current Ratio | 4.03 |
| Quick Ratio | 3.71 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -188.05% and return on invested capital (ROIC) is -110.26%.
| Return on Equity (ROE) | -188.05% |
| Return on Assets (ROA) | -102.63% |
| Return on Invested Capital (ROIC) | -110.26% |
| Return on Capital Employed (ROCE) | -212.67% |
| Weighted Average Cost of Capital (WACC) | 4.47% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$523,000 |
| Employee Count | 54 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Modular Medical has paid $2,000 in taxes.
| Income Tax | 2,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -79.06% in the last 52 weeks. The beta is 0.05, so Modular Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.05 |
| 52-Week Price Change | -79.06% |
| 50-Day Moving Average | 4.42 |
| 200-Day Moving Average | 10.70 |
| Relative Strength Index (RSI) | 50.76 |
| Average Volume (20 Days) | 123,708 |
Short Selling Information
The latest short interest is 92,368, so 1.71% of the outstanding shares have been sold short.
| Short Interest | 92,368 |
| Short Previous Month | 114,493 |
| Short % of Shares Out | 1.71% |
| Short % of Float | 1.99% |
| Short Ratio (days to cover) | 4.04 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -27.56M |
| Pretax Income | -28.24M |
| Net Income | -28.24M |
| EBITDA | -25.89M |
| EBIT | -27.56M |
| Earnings Per Share (EPS) | -$12.36 |
Balance Sheet
The company has $6.94 million in cash and $393,000 in debt, with a net cash position of $6.55 million or $1.21 per share.
| Cash & Cash Equivalents | 6.94M |
| Total Debt | 393,000 |
| Net Cash | 6.55M |
| Net Cash Per Share | $1.21 |
| Equity (Book Value) | 12.96M |
| Book Value Per Share | 2.78 |
| Working Capital | 5.67M |
Cash Flow
In the last 12 months, operating cash flow was -$23.75 million and capital expenditures -$3.93 million, giving a free cash flow of -$26.12 million.
| Operating Cash Flow | -23.75M |
| Capital Expenditures | -3.93M |
| Depreciation & Amortization | 1.56M |
| Net Borrowing | n/a |
| Free Cash Flow | -26.12M |
| FCF Per Share | -$4.83 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Modular Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -63.25% |
| Shareholder Yield | -63.25% |
| Earnings Yield | -115.94% |
| FCF Yield | -107.24% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 31, 2026. It was a reverse split with a ratio of 1:30.
| Last Split Date | Mar 31, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |